Optopatch: high-throughput all-optical electrophysiology for neural recording
Award amount
$678,000Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Q-State Biosciences, Inc.
- Proposal award date
- 2014-04-01
- Contract end date
- 2016-03-31
- UEI
- WWSMK3N4BCJ7
- Solicitation number
- PA11-134
- Topic code
- 102
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- An antisense oligonucleotide therapy for KCNT1 based epileptic encephalopathies
- Targeting ALS-linked FUS with allele-specific antisense oligonucleotides
- Anti-sense oligonucleotide platform for rare genetic diseases of the nervous system
- A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling
- An all-optical electrophysiology platform for the discovery of pain therapeutics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
17 SBIR/STTR records share this UEI (2014–2020). Reported award amounts total $15,040,936. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services